-1722511478674.svg){kind=small}
Published 06:59 IST, September 13th 2024
MBX Biosciences raises $163.2 mln in US IPO
The biotechnology company priced its offering of 10.2 million shares at $16 apiece, at the high-end of its targeted range of $14 to $16 each.
MBX Biosciences IPO 2024 | Image:
Unsplash, MBX Biosciences
- Listen to this article
- 2 min read
Advertisement
06:59 IST, September 13th 2024